Compare MDXG & EEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MDXG | EEX |
|---|---|---|
| Founded | 2006 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 880.2M |
| IPO Year | 2007 | N/A |
| Metric | MDXG | EEX |
|---|---|---|
| Price | $4.51 | $4.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $10.00 | $7.70 |
| AVG Volume (30 Days) | ★ 796.7K | 29.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.38% |
| EPS Growth | ★ 14.29 | N/A |
| EPS | ★ 0.32 | N/A |
| Revenue | ★ $418,630,000.00 | N/A |
| Revenue This Year | N/A | $16.88 |
| Revenue Next Year | $13.14 | $6.97 |
| P/E Ratio | ★ $14.88 | $236.96 |
| Revenue Growth | ★ 19.99 | N/A |
| 52 Week Low | $4.70 | $3.22 |
| 52 Week High | $8.20 | $5.45 |
| Indicator | MDXG | EEX |
|---|---|---|
| Relative Strength Index (RSI) | 25.08 | 40.76 |
| Support Level | N/A | $3.42 |
| Resistance Level | $5.38 | $4.96 |
| Average True Range (ATR) | 0.19 | 0.22 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 3.57 | 37.78 |
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
Emerald Holding Inc is a business-to-business (B2B) event organizer principally in the United States. The company is engaged in three complementary business lines; Connections division consists of a collection of B2B trade show franchises and other live events that provide exhibitors opportunities to engage with buyers and expand their brand's awareness in their industry; the Content division consists of B2B print publications and digital media products that complement existing trade show properties, and the Commerce division which offers software-as-a-service technology that enables year-round B2B buying and selling through Elastic Suite and Bulletin platforms for use by its customers. The Majority of the revenue for the company is generated from its Connections segment.